1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Infectious Disease Testing Market in the US 2015-2019

Infectious Disease Testing Market in the US 2015-2019

  • January 2016
  • -
  • Infiniti Research Limited
  • -
  • 66 pages

About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:
- Molecular diagnostic test
- POCT
- Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:
- HIV
- Respiratory
- HAIs
- Sexual health
- Tropical diseases
- Hepatitis

In addition, the market is segmented based on products:
- Equipment
- Consumables

Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five Key vendorsin the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
- Abbott Diagnostics
- Alere
- Beckman Coulter Diagnostics
- Roche
- Siemens Healthcare


Other prominent vendors
- Abaxis
- Acon Laboratories
- Avioq
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Chembio Diagnostic Systems
- Clarity Diagnostics
- EMD Millipore
- Epitope Diagnostic
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
- Life Technologies
- Maxim Biomedical
- Mindray
- OraSure Technologies
- Ortho Clinical Diagnostics
- Quidel Corporation
- Thermo Fisher Scientific
- Trinity Biotech

Market driver
- North America free trade agreement
- For a full, detailed list, view our report

Market challenge
- Medical device excise tax law
- For a full, detailed list, view our report

Market trend
- Development of innovative diagnostics initiatives
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Infectious Disease Testing Market in the US 2015-2019
PART 01: Executive summary
- Highlights
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
- Key market highlights
PART 05: Market landscape
- Market overview
PART 06: Infectious disease landscape in the US
- Reimbursement in US
- Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
- Five forces analysis
PART 07: Market segmentation by technology
- Molecular diagnostic test
- POCT for infectious diseases
- Immunodiagnostic tests
PART 08: Market segmentation by application
PART 09: Market segmentation by product
- Equipment
- Consumables
PART 10: Market drivers
- NAFTA
- Demand for rapid and automated diagnostics
- Shift toward patient-centered model
- Focus on disease management
PART 11: Impact of drivers
PART 12: Market challenges
- Medical device excise tax law
- Increase in globalization
- New microbial diseases
PART 13: Impact of drivers and challenges
PART 14: Market trends
- Development of innovative diagnostics initiatives
- Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
- Low-cost microfluidic devices for POCT
- Focus on early diagnosis of infectious diseases
PART 15: Vendor landscape
- Competitive scenario
- Abbott Diagnostics
- Alere
- Roche Diagnostics
- Siemens Healthcare
- Beckman Coulter Diagnostics
- Other prominent vendors
PART 16: Key vendor analysis
- Abbott Diagnostics
- Alere
- Beckman Coulter
- Roche Diagnostics
- Siemens Healthcare
PART 17: Appendix
- List of abbreviations
PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions)
Exhibit 03: Average Medicare payments for infectious diseases
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of infectious disease testing market in US based on technology
Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions)
Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
Exhibit 09: Segmentation of infectious disease market in US by technology 2014
Exhibit 10: POCT for infectious diseases market in US by application
Exhibit 11: Segmentation of POCT for infectious disease market in US 2014
Exhibit 12: Infectious disease testing market in US by product
Exhibit 13: Segmentation of infectious disease testing market in US by product 2014
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key Takeaways: Abbott Diagnostics
Exhibit 17: Key takeaways: Alere
Exhibit 18: Key takeaways: Roche Diagnostics
Exhibit 19: Key takeaways: Siemens Healthcare
Exhibit 20: Key takeaways: Beckman Coulter Diagnostics
Exhibit 21: Abbott Diagnostics: Key business offerings
Exhibit 22: Alere: Business segmentation by revenue 2014
Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 25: Beckman Coulter: Business segmentation
Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014
Exhibit 29: Siemens Healthcare: Business segmentation
Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.